The 13th Product Selection & Pipeline Optimization for Generics 2020 is a conference focused on best tactics and techniques for positioning portfolios to achieve compliance and overcome the current regulatory unknowns in the generics industry.
The13th Product Selection & Pipeline Optimization for Generics 2020 covers topics such as:
Strategic partnership and licensing agreements to maximize portfolio capacity and ROI
Product selection framework to enhance performance in line with portfolio initiatives
Portfolio management to ensure and maintain speed to market
Pproduct rationalization process to predict product viability and success
Keep pace with the fast-paced generics market to achieve a competitive advantage and market exclusivity
The 13th Product Selection & Pipeline Optimization for Generics 2020 is intended for Vice Presidents, Senior Vice Presidents, Senior Managers and Directors from generic and branded pharmaceutical companies and API companies responsible for:
Portfolio and Project Management
Intellectual Property / General Counsel
Biologics / Biosimilars
Patents / Patent Litigation
The 13th Product Selection & Pipeline Optimization for Generics 2020 might be held in United States in September 2020 (Not Final).